Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind Phase III Trial to Evaluate Efficacy and Safety of BI 695502 Plus Chemotherapy Versus Avastin® Plus Chemotherapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
Conditions
Interventions
BI 695502
Avastin
Locations
189
United States
Pacific Cancer Medical Center, Inc.
Anaheim, California, United States
Comprehensive Blood and Cancer Center
Bakersfield, California, United States
Lalita Pandit, M.D., Inc.
Fountain Valley, California, United States
Southern California Oncology Research Alliance
Los Angeles, California, United States
Innovative Clinical Research, Inc.
Whittier, California, United States
Ashland Bellefonte Cancer Center
Ashland, Kentucky, United States
Start Date
July 8, 2015
Primary Completion Date
June 30, 2017
Completion Date
November 16, 2018
Last Updated
January 13, 2020
NCT06855771
NCT06758401
NCT06120140
NCT06667908
NCT04165798
NCT06875310
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions